Press Releases

Month Year

Month Year

Mar 15, 2005

Insmed to Release Fourth Quarter and Year End Financial Results; Wednesday, March 16

Read more
Mar 15, 2005

Insmed Announces Completion of $35 Million Financing

Read more
Mar 10, 2005

FDA Accepts for Review Insmed's NDA for SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome

Read more
Feb 22, 2005

Insmed Provides Response to United States Patent Lawsuit; Seeks Immediate Dismissal or Summary Judgment for All Claims

Read more
Feb 16, 2005

Insmed Provides Response to UK Patent Lawsuit

Read more
Jan 7, 2005

University of Rochester Awarded $6.5 Million to Study Efficacy OF rhIGF-I/rhIGFBP-3, SomatoKine, in the Treatment of Myotonic Dystrophy

Read more
Jan 3, 2005

Insmed Submits New Drug Application -NDA- to Seek Regulatory Approval of SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome

Read more
Dec 31, 2004

Insmed Completes New Drug Application -NDA- for SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome; Conference Call Scheduled for 11:00 am January 5, 2005

Read more
Dec 30, 2004

Insmed Incorporated Released the Following Statement in Response to Recent Actions by Tercica, Inc.

Read more
Dec 21, 2004

Insmed Incorporated Released the Following Statement in Response to a Press Release Made Yesterday by Tercica, Inc.

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation